Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain

Bone Marrow Transplantation

Volumn 21, Issue 11, 1998, Pages 1155-1158

  Nagafuji, K ^a   Eto, T ^a   Hayashi, S ^a   Oshima, K ^b   Maeda, Y ^c   Gondo, H ^d   Inamura, T ^e   Niho, Y ^d  

^a HARASANSHIN HOSPITAL   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d First Department of Internal Medicine   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

Central nervous system; Donor lymphocyte transfusion; Epstein Barr virus associated lymphoproliferative disorder

Indexed keywords

HLA ANTIGEN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLAST CELL CRISIS; BRAIN INFECTION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; EPSTEIN BARR VIRUS; FEMALE; HEMIPARESIS; HUMAN; LYMPHOCYTE TRANSFUSION; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031833322     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701205     Document Type: Article

References (10)

1. Shapiro RS, McClain K, Frizzera G et al. Epstein-Barr virus associated with B cell lymphoproliferative disorder following bone marrow transplantation. Blood 1988; 71: 1234-1243.
2. Zutter MM, Martin PJ, Sale GE et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988; 72: 520-529.
3. Fisher A, Blanche S, Le Biodis J et al. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. New Engl J Med 1991; 324: 1451-1456.
4. Shapiro RS, Chauvenet A, McGuire W et al. Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. New Engl J Med 1988; 318: 1334-1339.
5. Hanto DW, Frizzera G, Gajl-Peczalska KJ et al. Acyclovir therapy of Epstein-Barr virus-induced posttransplant lymphoproliferative diseases. Transplant Proc 1985; 17: 89-92.
6. Papadopoulos EB, Ladanyi M, Emanuel D et al. Infusion of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New Engl J Med 1994; 330: 1185-1191.
7. Rooney CM, Smith CA, Ng CYC et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995; 345: 9-13.
8. Nagafuji K, Eto T, Hayashi S et al. Bone marrow transplantation from human T-cell leukaemia virus type 1-seropositive donor (submitted for publication).
9. Oshima K, Takeo H, Kikuchi M et al. Heterogeneity of Epstein-Barr virus infection on angioimmumoblastic lymphoadenopathy type T-cell lymphoma. Histopathology 1994; 25: 569-579.
10. Clinque P, Brytting M, Vago L et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993; 342: 398-401.